Skip to main content
SpringerLink
Log in

Synthetic glycans provide insight into the binding properties of toxic serum antibodies

  • Research Briefing
  • Published:

From Nature Synthesis

View current issue Submit your manuscript

A chemoenzymatic strategy is introduced whereby a glycan backbone is assembled enzymatically to give a core oligosaccharide that is subjected to chemical manipulations to install terminal epitopes. A library of oligosaccharides containing the human natural killer-1 epitope was synthesized, enabling evaluation of the binding specificities of serum antibodies of patients with anti-myelin-associated glycoprotein neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Our alternative strategy for the chemoenzymatic synthesis of glycans.

References

  1. Cummings, R. D. & Pierce, J. M. The challenge and promise of glycomics. Chem. Biol. 21, 1–15 (2014). A review article that describes the scope of glycoscience in biomedicine.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Boltje, T. J., Buskas, T. & Boons, G. J. Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Nat. Chem. 1, 611–622 (2009). A review that presents different synthetic approaches for the preparation of glycans.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Moremen, K. W. & Haltiwanger, R. S. Emerging structural insights into glycosyltransferase-mediated synthesis of glycans. Nat. Chem. Biol. 15, 853–864 (2019). This paper reports the recombinant expression of a wide panel of human glycan-processing enzymes.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Morise, J., Takematsu, H. & Oka, S. The role of human natural killer-1 (HNK-1) carbohydrate in neuronal plasticity and disease. Biochim. Biophys. Acta Gen. Subj. 1861, 2455–2461 (2017). A review article that presents the biological properties of HNK-1 epitopes.

    Article  CAS  PubMed  Google Scholar 

  5. Dalakas, M. C. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther. Adv. Neurol. Disord 11, 1756285617746640 (2018). A review article that discusses the scope and limitations of diagnostics for MAG neuropathy.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Bunyatov, M. et al. Chemoenzymatic synthesis of human natural killer-1-containing glycans and application as serum antibodies probes. Nat. Synth. https://doi.org/10.1038/s44160-023-00394-4 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Synthetic glycans provide insight into the binding properties of toxic serum antibodies. Nat. Synth 3, 15–16 (2024). https://doi.org/10.1038/s44160-023-00395-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44160-023-00395-3

  • Springer Nature Limited

Search

Navigation